EULAR recommendations - lay summaries
EULAR has published recommendations for, among others, the management of several rheumatic and musculoskeletal diseases addressed to our community. For EULAR it is essential that the dissemination of these recommendations reaches patients’ organisations as well as healthcare professionals to support patients and carers to manage their disease.
Therefore EULAR now provides lay summaries of all recommendations, in English, and calls on all interested organisations to disseminate them and encourage the translation of these lay versions in their own language.
Heidi A Zangi, Mwidimi Ndosi, Jo Adams, Lena Andersen, Christina Bode, Carina Boström, Yvonne van Eijk-Hustings, Laure Gossec, Jana Korandová, Gabriel Mendes, Karin Niedermann, Jette Primdahl, Michaela Stoffer, Marieke Voshaar, Astrid van Tubergen
EULAR recommendations for patient education for people with inflammatory arthritis
Ann Rheum Dis 2015;74:954-962 doi:10.1136/annrheumdis-2014-206807
Read this recommendation
N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens, J W J Bijlsma
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
Ann Rheum Dis published 19 July 2013, 10.1136/annrheumdis-2013-203249
Guidelines to translate EULAR recommendations - lay summaries
Please note that comprehensive guidelines have been developed to ensure the correct translation of the recommendations.
Please read them carefully before translating as mandatory rules apply. Thank you for helping us to disseminate science within your community.
For further information please contact: Florian Klett (email@example.com)
ARD lay summaries
The Annals of the Rheumatic Diseases (ARD) now also provides short research summaries for patients and non-clinicians to accompany selected key research papers published in the journal. These aim to clearly explain the results of the research studies as well as any implications for treatment of the specific condition. The summaries are written in plain language in a consistently structured format and checked for accuracy and readability by expert rheumatologists and people from EULAR’s patient research partner network.